Back to search

France· FR:69848594

FESOTERODINE ARROW LP 4 mg, comprimé à libération prolongée

A fesoterodine product containing fumarate de fésotérodine, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC G04BD11

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFESOTERODINE ARROW LP 4 mg, comprimé …ATCG04BD11REGISTER NO.FR:69848594PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Fesoterodine is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD11 (fesoterodine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose

Fesoterodine · ATC G04BD11

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fesoterodine costs, country by country.

Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.19 in France to $1.14 in Switzerland — a ×6.0 gap.

  • France: $0.19 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Fesoterodine · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.14
  • ES Spain$0.73
  • IT Italy$0.32
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FUMARATE DE FÉSOTÉRODINE
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
G04BD11
ATC class
Fesoterodine
Defined daily dose
4 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930255131
    plaquette(s) aluminium de 30 comprimé(s)
    EUR 6.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

191 interactions on record for fesoterodine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fesoterodine · interactions on record

191 records

  • 9 severe
  • 141 moderate

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe
  • Darunavir and cobicistatJ05AR14severe

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fesoterodine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fesoterodine products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Belgium · Fesoterodin Eg, Fesoterodine Ab
  • Cyprus · Fesoterodine Accord, Fesoterodine Ariti
  • Czechia · Fesoterodine Accord, Fesoterodine Aristo
  • Germany · Fesoterodin Al, Fesoterodin Aristo
  • Denmark · Fesoterodin Accord, Fesoterodine Medical Valley
  • Spain · Fesoterodina Alter, Fesoterodina Aristo
  • Finland · Fesoteridone Accord, Fesoterodine Accord
  • United Kingdom (Northern Ireland) · Fesoterodine Fumarate Accord, Fesoterodine Fumarate Aspire
  • Greece · Fesoterodine Ariti, Φεσοτεροδίνη
  • Hungary · Fesoterodine Stada, Fesoterodine Viatris
  • Ireland · Fesoterodine Accord, Fesoterodine Aristo
  • Iceland · Fesoterodine Medical Valley, Fesoterodine Stada
  • Italy · Arionte, Fesoterodina Doc
  • Liechtenstein · Toviaz
  • Lithuania · Zecatrin
  • Luxembourg · Fesoterodine Eg
  • Latvia · Zecatrin
  • Malta · Fesoterodine Viatris
  • Netherlands · Fesoterodine Accord, Fesoterodine Cf
  • Norway · Fesoterodin Accord, Fesoterodine Accord
  • Portugal · Fesoterodina, Fesoterodina Generis
  • Sweden · Fesoterodine Accord, Fesoterodine Medical Valley
  • Slovakia · Sokar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b10bb7e3-84e2-4b3f-9570-f4bb4f736f1d
GET /v1/drugs/b10bb7e3-84e2-4b3f-9570-f4bb4f736f1d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69848594",
  "date_amm": "2022-06-10",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "FUMARATE DE FÉSOTÉRODINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about fesoterodine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.